• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名系统性硬化症患者出现的快速进展性致命性间质性肺疾病。

Rapidly progressive fatal interstitial lung disease in a patient with systemic sclerosis.

作者信息

Phillips Kristine, Byrne-Dugan Cathryn, Batterson Eric, Seibold James R

机构信息

University of Michigan, Ann Arbor, MI 48103, USA.

出版信息

Nat Rev Rheumatol. 2009 Apr;5(4):225-8. doi: 10.1038/nrrheum.2009.30.

DOI:10.1038/nrrheum.2009.30
PMID:19337287
Abstract

BACKGROUND

A 36-year-old woman developed new-onset Raynaud phenomenon and rapidly progressive dyspnea over a 2-week period. A lung biopsy demonstrated pauci-inflammatory nonspecific pneumonitis, which proved refractory to systemic corticosteroid and intravenous cyclophosphamide therapy. Her preterminal course in an intensive care unit was typified by sequential organ failure. Postmortem examination showed extensive organ fibrosis, including severe diffuse alveolar damage and parenchymal fibrosis, and a notable lack of potentially treatable tissue inflammation.

INVESTIGATIONS

Chest radiography, physical examination, screening for autoantibodies, measurement of serum creatinine, creatine phosphokinase, and brain natriuretic peptide levels, cardiac examination, pulmonary function tests, electrocardiography, transthoracic Doppler echocardiography, right heart catheterization, high-resolution thoracic CT, pulmonary ventilation/perfusion scan, lung biopsy.

DIAGNOSIS

Interstitial lung disease associated with diffuse systemic sclerosis.

MANAGEMENT

Treatment with oxygen, oral and intravenous corticosteroids, mycophenolate mofetil and intravenous cyclophosphamide.

摘要

背景

一名36岁女性在2周内出现新发雷诺现象并迅速进展为呼吸困难。肺活检显示少炎性非特异性肺炎,对全身用糖皮质激素和静脉用环磷酰胺治疗无效。她在重症监护病房临终前的病程以序贯性器官衰竭为特征。尸检显示广泛的器官纤维化,包括严重的弥漫性肺泡损伤和实质纤维化,且明显缺乏潜在可治疗的组织炎症。

检查

胸部X线检查、体格检查、自身抗体筛查、血清肌酐、肌酸磷酸激酶和脑钠肽水平测定、心脏检查、肺功能测试、心电图、经胸多普勒超声心动图、右心导管检查、高分辨率胸部CT、肺通气/灌注扫描、肺活检。

诊断

与弥漫性系统性硬化症相关的间质性肺疾病。

治疗

吸氧、口服和静脉用糖皮质激素、霉酚酸酯和静脉用环磷酰胺治疗。

相似文献

1
Rapidly progressive fatal interstitial lung disease in a patient with systemic sclerosis.一名系统性硬化症患者出现的快速进展性致命性间质性肺疾病。
Nat Rev Rheumatol. 2009 Apr;5(4):225-8. doi: 10.1038/nrrheum.2009.30.
2
[Interstitial lung disease in systemic sclerosis].[系统性硬化症中的间质性肺疾病]
Presse Med. 2006 Dec;35(12 Pt 2):1943-51. doi: 10.1016/s0755-4982(06)74929-6.
3
Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease.使用6分钟步行试验评估的运动能力:弥漫性系统性硬化症和初始间质性肺病患者的5年结果。
Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S142-7. Epub 2015 Sep 1.
4
Expert Perspectives On Clinical Challenges: Expert Perspectives: Challenges in Scleroderma.专家视角:临床挑战:硬皮病相关挑战。
Arthritis Rheumatol. 2020 Sep;72(9):1415-1426. doi: 10.1002/art.41406. Epub 2020 Aug 9.
5
Systemic sclerosis-associated interstitial lung disease.系统性硬皮病相关性间质性肺疾病。
Lancet Respir Med. 2020 Mar;8(3):304-320. doi: 10.1016/S2213-2600(19)30480-1. Epub 2020 Feb 27.
6
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.霉酚酸酯与口服环磷酰胺治疗硬皮病相关间质性肺病(SLS II):一项随机对照、双盲、平行组试验。
Lancet Respir Med. 2016 Sep;4(9):708-719. doi: 10.1016/S2213-2600(16)30152-7. Epub 2016 Jul 25.
7
Fatal rapidly progressive interstitial pneumonitis associated with amyopathic dermatomyositis and CD8 T lymphocytes.与无肌病性皮肌炎及CD8 T淋巴细胞相关的致死性快速进展性间质性肺炎
J Intensive Care Med. 2005 May-Jun;20(3):160-3. doi: 10.1177/0885066605275391.
8
The natural course of progressive systemic sclerosis patients with interstitial lung involvement.伴有间质性肺受累的进行性系统性硬化症患者的自然病程。
Clin Rheumatol. 2007 Mar;26(3):349-54. doi: 10.1007/s10067-006-0302-6. Epub 2006 Apr 25.
9
Evidence-based management of rapidly progressing systemic sclerosis.基于证据的快速进展性系统性硬化症的管理。
Best Pract Res Clin Rheumatol. 2010 Jun;24(3):387-400. doi: 10.1016/j.berh.2009.12.002.
10
Interstitial lung disease in systemic sclerosis.系统性硬皮病中的间质性肺疾病。
Autoimmun Rev. 2011 Mar;10(5):248-55. doi: 10.1016/j.autrev.2010.09.012. Epub 2010 Sep 21.

引用本文的文献

1
Multidisciplinary approach to anti-MDA5 antibody-positive dermatomyositis associated with rapidly progressive interstitial lung disease.多学科方法治疗抗 MDA5 抗体阳性皮肌炎伴快速进展性间质性肺病。
BMJ Case Rep. 2022 Mar 2;15(3):e246192. doi: 10.1136/bcr-2021-246192.

本文引用的文献

1
Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies.环磷酰胺对硬皮病和间质性肺病患者肺功能的影响:一项对随机对照试验和观察性前瞻性队列研究的系统评价和荟萃分析
Arthritis Res Ther. 2008;10(5):R124. doi: 10.1186/ar2534. Epub 2008 Oct 20.
2
Scleroderma lung disease: "if you don't know where you are going, any road will take you there".硬皮病肺病:“如果你不知道要去往何方,那么任何一条路都会把你带到那里”。
Am J Respir Crit Care Med. 2008 Jun 1;177(11):1178-9. doi: 10.1164/rccm.200802-304ED.
3
Oral cyclophosphamide for active scleroderma lung disease: a decision analysis.
口服环磷酰胺治疗活动性硬皮病肺病:一项决策分析。
Med Decis Making. 2008 Nov-Dec;28(6):926-37. doi: 10.1177/0272989X08317015. Epub 2008 Apr 28.
4
Interstitial lung disease in systemic sclerosis: a simple staging system.系统性硬化症中的间质性肺疾病:一种简易分期系统。
Am J Respir Crit Care Med. 2008 Jun 1;177(11):1248-54. doi: 10.1164/rccm.200706-877OC. Epub 2008 Mar 27.
5
Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization.系统性硬化症患者肺动脉高压的评估:非侵入性检查与右心导管检查结果的比较。
J Rheumatol. 2008 Mar;35(3):458-65. Epub 2008 Jan 15.
6
Bronchoalveolar cellular analysis in scleroderma lung disease: does Sutton's law hold?硬皮病肺病中的支气管肺泡细胞分析:萨顿定律是否适用?
Am J Respir Crit Care Med. 2008 Jan 1;177(1):2-3. doi: 10.1164/rccm.200710-1490ED.
7
Daily cyclophosphamide for scleroderma: are patients with the most to gain underrepresented in this trial?用于治疗硬皮病的每日环磷酰胺疗法:在该试验中获益最大的患者群体是否未得到充分体现?
Am J Respir Crit Care Med. 2007 Nov 15;176(10):952-3. doi: 10.1164/rccm.200708-1185ED.
8
The spectrum of scleroderma lung disease.硬皮病肺部疾病的谱系
Semin Respir Crit Care Med. 2007 Aug;28(4):418-29. doi: 10.1055/s-2007-985613.
9
Interstitial lung disease in systemic sclerosis.系统性硬化症中的间质性肺疾病
Lung. 2007 Jul-Aug;185(4):211-20. doi: 10.1007/s00408-007-9012-3.
10
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.环磷酰胺1年治疗对硬皮病肺病2年预后的影响。
Am J Respir Crit Care Med. 2007 Nov 15;176(10):1026-34. doi: 10.1164/rccm.200702-326OC. Epub 2007 Aug 23.